metricas
covid
Buscar en
Gastroenterología y Hepatología
Toda la web
Inicio Gastroenterología y Hepatología Calidad de vida y personalidad en la enfermedad inflamatoria intestinal
Journal Information
Vol. 32. Issue S2.
Psicología y enfermedad inflamatoria intestinal
Pages 3-8 (October 2009)
Share
Share
Download PDF
More article options
Vol. 32. Issue S2.
Psicología y enfermedad inflamatoria intestinal
Pages 3-8 (October 2009)
Psicología y enfermedad inflamatoria intestinal
Full text access
Calidad de vida y personalidad en la enfermedad inflamatoria intestinal
Quality of life and personality in inflammatory bowel disease
Visits
4017
Margarita Gili
Corresponding author
mgili@uib.es

Autor para correspondencia.
, Natalia Bauzà
Instituto Universitario de Investigación en Salud (IUNICS), Universitat de les Illes Balears, Palma de Mallorca, España
This item has received
Article information
Resumen

En este artículo se revisan estudios recientes que analizan la relación entre calidad de vida relacionada con la salud (CVRS) y la personalidad con la enfermedad inflamatoria intestinal (EII). La CVRS es especialmente importante en el caso de las enfermedades crónicas, ya que el alivio de los síntomas, el retraso en su progresión y las mejorías en la calidad funcional son objetivos estratégicos del tratamiento. Algunos estudios muestran que la CVRS en pacientes con EII es significativamente más baja que en la población general. Hay pocos estudios que relacionen la personalidad con la EII y no hay homogeneidad en los resultados. Los trastornos de personalidad más prevalentes en la EII son el trastorno de personalidad por evitación y el trastorno obsesivo compulsivo de la personalidad. Se presentan algunos resultados de un estudio longitudinal que corroboran una peor CVRS en estos pacientes y la presencia de uno o más trastornos de la personalidad en un 57% de la muestra.

Palabras clave:
Calidad de vida relacionada con la salud
Enfermedad inflamatoria intestinal
Trastorno de personalidad
Abstract

The present article reviews recent studies analyzing the association between healthrelated quality of life (HRQoL) and personality in inflammatory bowel disease (IBD). HRQoL is especially important in chronic diseases, since the strategic goals of treatment are to relieve symptoms, delay progression and improve functional quality. Some studies show that HRQoL in patients with IBD is significantly lower than that in the general population. Few studies have analyzed the association between personality and IBD and the results are contradictory. The most prevalent personality disorders in IBD are avoidant personality disorder and obsessive-compulsive personality disorder. Some results of a longitudinal study corroborating impaired HRQoL in these patients and the presence of one or more personality disorders in 57% of the sample are discussed.

Keywords:
Health-related quality of life
Inflammatory bowel disease
Personality disorder
Full text is only aviable in PDF
Bibliografía
[1.]
L. Ferrucci, S. Baldasseroni, S. Bandinelli, W. De Alfieri, A. Cartei, D. Calvani, et al.
Disease severity and health-related quality of life across different chronic conditions.
J Am Geriatr Soc, 48 (2000), pp. 1490-1495
[2.]
H. Keles, A. Ekici, M. Ekici, E. Bulcun, V. Altinkaya.
Effect of chronic diseases and associated psychological distress on health-related quality of life.
Int Med J, 37 (2008), pp. 6-11
[3.]
R.L. Schalock.
Quality of life: conceptualization and measurement.
American Association on Mental Retardation, (1996),
[4.]
M. Roca, M. Bernardo.
Trastornos depresivos en patologías médicas.
Masson, (1996),
[5.]
E.J. Irvine.
Quality of life of patients with ulcerative colitis: past, present, and future.
Inflamm Bowel Dis, 14 (2008), pp. 554-565
[6.]
K. Nordin, K. Pahlman, M. Larsson, M. Sundberg-Hjelm, L. Lööf.
Health –related quality of life an psychological distress in a population-based sample of Swedish patients with inflammatory bowel disease.
Scand J Gastroenterol, 37 (2002), pp. 450-457
[7.]
T. Bernklev, J. Jahnsen, I. Lygren, M. Henriksen, M. Vant, B. Moum.
Health-related quality of life in patients with inflammatory bowel disease measured with the Short Form-36: psychometric assessments and a comparison with general population norms.
Infalmm Bowel Dis, 11 (2005), pp. 909-918
[8.]
D.A. Drossman, W.E. Whitehead, B.B. Tonner, N. Diamant, Y.J. Hu, S.I. Bangdiwala, et al.
What determines severity among patients with painful functional bowel disorders?.
Am J Gastroenterol, 95 (2000), pp. 974-980
[9.]
J. Málek, A. Kurzová, T. Vedral, Z. Pélak, M. Ambrus.
Progress in surgical treatment may improve the quality of life in patients with breast surgery for malignant tumors.
Rozhl Chir, 82 (2003), pp. 83-87
[10.]
L.M. Lix, L.A. Graff, J.R. Walker, I. Clara, P. Rawsthorne, L. Rogala, et al.
Longitudinal study of quality of life and psychological functioning for active, fluctuating, and inactive disease patterns in inflammatory bowel disease.
Inflamm Bowel Dis, 14 (2008), pp. 1-10
[11.]
W. Reinisch, W.J. Sandborn, M. Bala, S. Yan, B.G. Feagan, P. Rutgeerts, et al.
Response and remission are associated with improved quality of life employment and disability status, hours worked, and productivity of patients with ulcerative colitis.
Inflamm Bowel Dis, 13 (2007), pp. 1135-1140
[12.]
A.G. Pallis, I.G. Vlachonikolis, I.A. Mouzas.
Assessing health-related quality of life in patients with inflammatory bowel disease, in Crete, Greece.
BMC Gastroenterol, 2 (2002), pp. 1
[13.]
F. Casellas, J. López-Vivancos, A. Casado, J.R. Malagelada.
Factors affecting health related quality of life of patients with inflammatory bowel disease.
Quality of Life Research, 11 (2002), pp. 775-781
[14.]
F. Casellas, I.J. Arenas, J.S. Baudet, S. Fábregas, J. Gelabert, C. Medina, et al.
Impairment of health-related quality of life in patients with inflammatory bowel disease: A Spanish Multicenter Study.
Inflamm Bowel Disease, 11 (2005), pp. 488-496
[15.]
J. Casati, B.B. Toner.
Psychosocial aspects of inflammatory bowel disease.
Biomed & Pharmacother, 54 (2000), pp. 388-393
[16.]
F. llas, J. López-Vivancos, X. Badía, J. Vilaseca, J.R. Malagelada.
Impact of surgery for Crohn's disease on health related quality of life.
Am J Gastroenterol, 95 (2000), pp. 177-182
[17.]
G. Engel.
Studies of ulcerative colitis. III. The nature of the psychologic processes.
Am J Med, 19 (1955), pp. 231-256
[18.]
B. Gerbert.
Psychological aspects of Crohn's disease.
J Behav Med, 3 (1980), pp. 41-58
[19.]
D.A. Robertson, J. Ray, I. Diamond, J.G. Edwards.
Personality profile and affective state of patients with inflammatory bowel disease.
Gut, 30 (1989), pp. 623-626
[20.]
B. Boye, J. Jahnsen, K. Mokleby, S. Leganger, G. Jantschek, I. Jantschek, et al.
The INSPIRE Study: Are Different Personality Traits Related to Disease-Specific Quality of Life (IBDQ) in distressed patients with ulcerative colitis and Crohn's disease?.
Inflamm Bowel Dis, 14 (2008), pp. 680-686
[21.]
R. Verissimo, R. Mota-Cardoso, G. Taylor.
Relationships between alexithymia, emotional control, and quality of life in patients with inflammatory bowel disease.
Psychother Psychosom, 67 (1998), pp. 75-80
[22.]
B. Moreno-Jiménez, B. López Blanco, A. Rodríguez-Muñoz, E. Garrosa Hernández.
The influence of personality factors on healthrelated quality of life of patients with inflammatory bowel disease.
Journal of Psychosomatic Research, 62 (2007), pp. 39-46
[23.]
S.M. Barret, P.J. Standen, A.S. Lee, C.J. Hawkey, R.F. Logan.
Personality, smoking and inflammatory bowel disease.
Eur J Gastroenterol Hepatol, 8 (1996), pp. 651-655
[24.]
A. Vidal, E. Gómez-Gil, M. Sans, M.J. Portella, M. Salamero, J.M. Piqué, et al.
Health-related quality of life in inflammatory bowel disease patients: the role of psychopathology and personality.
Infamm Bowel Dis, 14 (2008), pp. 977-983
Copyright © 2009. Elsevier España S.L.. Todos los derechos reservados
Download PDF
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos